Though the style of the paintings is utterly contemporary, the mood somehow evokes both family photos in the living room and ...
February is American Heart Month, which is an appropriate time to learn how genetic testing can protect your family.
This month’s KELOLAND Living Book Club selection examines the history of the Sackler family, including the founding of Purdue Pharma, its role in the marketing of pharmaceuticals, and the family ...
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...
A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack. Most of the money from a newly-reached settlement over the fallout of the ...
Purdue Pharma and its Sackler family owners have reached a new US$7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid ...
Not every state has signed on yet. Under the new proposal, members of the Sackler family would also give up ownership of Purdue. They've already stepped down from the company's board and have ...
The Sackler family and Purdue Pharma have agreed to a combined $7.4 billion settlement, according to the Utah Department of Commerce. Utah’s share would be $57 million of it if the state agrees ...
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
The tentative deal is worth more than $7 billion. It includes the company's owners, members of the Sackler family. However, it does not give them immunity from future opioid lawsuits as the family ...
The deal comes after the US Supreme Court last year rejected a $6 billion pact that would have protected Purdue’s owners, members of the billionaire Sackler family, from any further litigation ...
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results